ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Expanding its contract manufacturing business, Wacker Chemie will acquire Genopis, a San Diego–based expert in plasmid DNA (pDNA) technology, from Helixmith for $39 million. Genopis operates a 500 L pDNA fermentation line and is building a small-scale fermentation facility. “The acquisition allows us to establish a local presence in the large US market for biologics,” Wacker CEO Rudolf Staudigl says in a press release. Wacker says it will work with Helixmith to produce a pDNA therapy for diabetic peripheral neuropathy.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter